Alan Smith grew up in southern England thinking he wanted to go into astronomy. But once at Christ's College in Cambridge, Smith realized that the required physics courses bored him. He switched his ...

has sent reverberations throughout the pharma and biotech industries. Marks, a well-respected hematologist oncologist who has been at the agency since 2012, said in his resignation letter his ...

CINCINNATI (Cincinnati Business Courier) - A growing biotech and pharmaceuticals manufacturer that announced a large investment in Greater Cincinnati a little over a year ago has unveiled new ...

Earlier this week, Novo Nordisk NVO signed an exclusive license agreement with China-based United Biotechnology for an experimental obesity drug in a deal valued at up to $2 billion. Through this ...

There are numerous potential causes for red spots to form on the skin, including sudden infections or underlying chronic conditions. On darker skin tones, the spots may appear as purplish or ...

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.

A New Jersey-based biotech is looking to become the main character in the age-related macular degeneration field. Character Biosciences has landed a $93 million series B to progress its precision ...

Shenzhen Zhongge Biotechnology Co. Ltd. prepared and tested cholesterol side-chain cleavage enzyme, mitochondrial (CYP11A1) inhibitors reported to be useful for the treatment of castration-resistant ...

The biotech industry may be cooling off, but there’s still plenty to be excited about when it comes to the underlying innovations. Chances are, the next great medical breakthrough is already in ...

For Rituja Suraj Chavan, Managing Director of Valient Biotech Pvt Ltd, starting a company was never just about business—it was about making a difference. The company was founded with a dual ...

The initiative also includes agreements with leading biotech firms Harbour BioMed, Syneron Bio, and BioKangtai. The new R&D center will focus on early-stage research, clinical development ...